623
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Environmental and personal barriers encountered in community pharmacy settings based on public opinions

ORCID Icon, , , , , , , & show all
Article: FSO933 | Received 18 Aug 2023, Accepted 01 Nov 2023, Published online: 28 May 2024

References

  • Ilardo ML, Speciale A. The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication. Int. J. Environ. Res. Public Health 17(2), (2020).
  • Schindel TJ, Breault RR, Hughes CA. “It Made a Difference to Me”: A Comparative Case Study of Community Pharmacists' Care Planning Services in Primary Health Care. Pharmacy (Basel) 7(3), (2019).
  • Hindi AMK, Schafheutle EI, Jacobs S. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients’, pharmacists' and GPs' experiences and expectations. BMC Fam. Pract. 20(1), 26 (2019).
  • Feehan M, Walsh M, Godin J, Sundwall D, Munger MA. Patient preferences for healthcare delivery through community pharmacy settings in the USA: a discrete choice study. J. Clin. Pharm. Ther. 42(6), 738–749 (2017).
  • Bach AT, Goad JA. The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integr. Pharm. Res. Pract. 4, 67–77 (2015).
  • Albasri A, Van Den Bruel A, Hayward G, Mcmanus RJ, Sheppard JP, Verbakel JYJ. Impact of point-of-care tests in community pharmacies: a systematic review and meta-analysis. BMJ Open 10(5), e034298 (2020).
  • Lertsinudom S, Kaewketthong P, Chankaew T, Chinwong D, Chinwong S. Smoking Cessation Services by Community Pharmacists: Real-World Practice in Thailand. Int. J. Environ. Res. Public Health 18(22), (2021).
  • Litvak I, Nguyen K, Pezzino NC. Community pharmacists' perceptions on their role in counseling patients on lifestyle modifications. J. Am. Pharm. Assoc. (2003) 63(4S), S57–S63; e52 (2023).
  • Kharaba Z, Feghali E, El Husseini F et al. An Assessment of Quality of Life in Patients With Asthma Through Physical, Emotional, Social, and Occupational Aspects. A Cross-Sectional Study. Front Public Health 10, 883784 (2022).
  • Jarab AS, Al-Qerem W, Alzoubi KH et al. Patterns of drug-related problems and the services provided to optimize drug therapy in the community pharmacy setting. Saudi Pharm. J. 31(9), 101746 (2023).
  • Dagnachew N, Meshesha SG, Mekonen ZT. A qualitative exploration of barriers in accessing community pharmacy services for persons with disability in Addis Ababa, Ethiopia: a cross sectional phenomenological study. BMC Health Serv. Res. 21(1), 467 (2021).
  • Jairoun AA, Al-Hemyari SS, Shahwan M et al. Access to community pharmacy services for people with disabilities: barriers, challenges, and opportunities. Res. Social Adm. Pharm. 18(5), 2711–2713 (2022).
  • Hakonsen H, Lees K, Toverud EL. Cultural barriers encountered by Norwegian community pharmacists in providing service to non-Western immigrant patients. Int. J. Clin. Pharm. 36(6), 1144–1151 (2014).
  • Cleland JA, Watson MC, Walker L, Denison A, Vanes N, Moffat M. Community pharmacists' perceptions of barriers to communication with migrants. Int. J. Pharm. Pract. 20(3), 148–154 (2012).
  • Chang E, Tsang B, Thornley S. Language barriers in the community pharmacy: a survey of northern and western Auckland. J. Prim. Health Care 3(2), 102–106 (2011).
  • Jarab AS, Al-Qerem W, Alzoubi KH et al. Public perception, satisfaction and expectations from community pharmacy services and the barriers to consult the community pharmacist. Int. J. Environ. Health Res. doi: 10.1080/09603123.2023.2231364 1–11 (2023).
  • El Hajj MS, Salem S, Mansoor H. Public's attitudes towards community pharmacy in Qatar: a pilot study. Patient Prefer. Adherence 5, 405–422 (2011).
  • Nsengimana A, Biracyaza E, Hategekimana JC, Tuyishimire J, Nyiligira J, Rutembesa E. Attitudes, perceptions, and barriers of community pharmacists in Rwanda towards health promotion: a cross sectional study. Arch. Public Health 80(1), 157 (2022).
  • Frankel GE, Austin Z. Responsibility and confidence: identifying barriers to advanced pharmacy practice. Can. Pharm. J. (Ott.) 146(3), 155–161 (2013).
  • Jarab AS, Al-Qerem W, Alzoubi KH et al. Artificial intelligence in pharmacy practice: attitude and willingness of the community pharmacists and the barriers for its implementation. Saudi Pharm. J 31(8), 101700 (2023).
  • Hamed SH. Community Pharmacy Practice During COVID-19 Pandemic: A Perspective From the Middle East. Glob J. Qual. Saf. Healthc 3(3), 109–114 (2020).
  • Akour A, Elayeh E, Tubeileh R, Hammad A, Ya'acoub R, Al-Tammemi AB. Role of community pharmacists in medication management during COVID-19 lockdown. Pathog. Glob Health 115(3), 168–177 (2021).
  • Ayenew W, Seid AM, Kasahun AE et al. Assessment of community pharmacy professionals' willingness, involvement, beliefs, and barriers to offer health promotion services: a cross-sectional study. BMC Health Serv. Res. 22(1), 1539 (2022).
  • King SR, King ER, Kuhl D, Peyton L. Health literacy and the quality of pharmacist-patient communication among those prescribed anticoagulation therapy. Res. Social Adm. Pharm. 17(3), 523–530 (2021).